Vnus endovenous laser ablation settlement
This article was originally published in The Gray Sheet
Executive Summary
AngioDynamics and Vascular Solutions gain non-exclusive licenses to Vnus Medical patents relating to disposable endovenous laser fiber kits, laser fibers and lasers used for endovenous laser ablation, in exchange for upfront payments of $6.8 million and $3.1 million, respectively, under a settlement of 2005 patent litigation, announced June 3. The license also requires ongoing royalty payments until September 2017 ("1The Gray Sheet" Oct. 8, 2007, In Brief)
You may also be interested in...
Varicose vein treatment patent case heads to trial
VNUS Medical Technologies' patent infringement case against competitors Diomed, AngioDynamics and Vascular Solutions is scheduled to go to trial Oct. 29 in the U.S. District Court in Northern California following the judge's denial of both sides' motions for summary judgment Oct. 2. VNUS, maker of the ClosureFAST radiofrequency system for treatment of varicose veins, alleged infringement of patents related to the technology in 2005. AngioDynamics replaced its VenaCure product with a modified NeverTouch VenaCure system in June after losing a separate patent suit to Diomed, maker of the EVLT endovenous laser treatment. Vascular Solutions also modified its Vari-Lase system as a result of that case (1"The Gray Sheet" April 16, 2007, p. 16)
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.